Invest in growth companies making a difference
Sciety makes it possible to become a shareholder in selected companies in the life science sector. Online and free of charge.
Sciety becomes a member in SwedenBIO - the trade association for Swedish life science.
EMPE Diagnostics - Closed successfully
Ten million people fall ill with tuberculosis every year and with an early diagnosis and correct treatment most people could get well. Yet, tuberculosis is the ninth most common cause of death in the world.
EMPE has developed a patented solution for rapid diagnostics, suitable for clinics with limited resources. The diagnostic test has been validated on clinical samples and sales start is estimated at the end of 2018.
Sciety is a digital investment network
Sciety combines medical and business competence to select promising growth companies in the life science sector. We give you the opportunity to invest in unlisted companies within digital health, medical technology and more.
Sciety takes care of selection and vetting, and manages the complete investment process. We offer investment opportunities in companies with the potential to give return on investment and make a difference.
Straightforward to invest
As a member, you will find all investment information online and you will also be invited to meet with the companies at our investor lunches.
Selling the share
Invest online and free of charge. You will own your shares directly in the companies and join their expansion. We focus on companies with clear exit plans.
The new issue of shares in EMPE Diagnostics was fully subscribed already two weeks before the subscription period expired. EMPE Diagnostics develops a rapid test for diagnosis of tuberculosis. In…Läs mer
Invest with us
Sciety gives members the opportunity to invest in unlisted growth companies with the potential to give return on investment and make a difference. We specialise in the life science sector.